Vascular access through a vein draining into the superior vena cava is commonly used for long-term infusion of drugs inr cancer chemotherapy; prolonged cannulation of the inferior vena cava is generally considered as having an excessively high complication rate.
Methods
Prolonged cisplatin infusion via the inferior vena cava by means of a Groshong catheter was evaluated in 20 consecutive patients with thoracic malignancies showing evidence of superior vena cava infiltration or obstruction.
Results
We achieved 1,291 catheter days for our survey with a mean duration of vascular access of 64.5 days per patient and a mean duration of infusion time of 40 days. There were 2 complications, a catheter obstruction after a 7-day rest period and an ileo-femoral thrombosis 6 days after catheter placement.
Conclusions
Our experience compared favourably with the results obtained by long-term central venous access via the supraumbilical route, and demonstrated the reliability and safety of this approach in cases where the superior vena cava cannulation is technically difficult or impossible.
AndersonA.J., KrasnowS.H., BoyerM.W.: Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest, 1: 71–75, 1989.
2.
AzizkhanR.G., TaylorL.A., JacquesP.F.: Percutaneous trans-lumbar and transhepatic inferior vena caval catheters for prolonged venous access in children. J. Pediatr. Surg., 27: 165–169, 1992.
3.
BediniA.V., TavecchioL., BonalumiM.G.: Reliability of prolonged infusion in cancer chemotherapy with the Groshong central venous catheter. Reg. Cancer. Treat., 3: 232–234, 1990.
4.
BernM.M., LokichJ.J., WallachS.R., BotheA.: Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann. Int. Med., 112: 423–428, 1990.
CarlsonR.W., SikicB.I.: Continuous infusion or bolus injection in cancer chemotherapy. Ann. Intern. Med., 99: 823–833, 1983.
10.
CrummyA.B., CarlsonP., McDermottJ.C., AndrewsD.: Percutaneous transhepatic placement of a Hickman catheter. AJR, 2: 1317–1318, 1989.
11.
CurtasS., BonaventuraM., MeguidM.M.: Cannulation of inferior vena cava for long term venous access. Surg. Gynecol. Obstet., 168: 121–124, 1989.
12.
DamascelliB., BonalumiM.G., MarchianoA., SpreaficoC., GarbagnatiE., MilellaM., ValvassoriL., BellegottiL., Ribol-diG.L., CecchettiG., SpagnoliI., RigilloG., SalvettiM., Segura: High technology long term central venous access: the radiological content. J. Intervent. Radiol., 5: 153–161, 1990.
13.
DamascelliB., BonalumiM.G., TernoG., PupaA., PredaF., SpreaficoC., TagliabueL.: Interventional radiology with venous port (chemotherapy infusional support). Europ. J. Radiol., 6: 210–214, 1986.
14.
DelmoreJ.E., HorbeltD.V., JackB.L.: Experience with the Groshong long-term central venous catheter. Gynecol. Oncol., 34: 216–218, 1989.
15.
DennyD.F.Jr.,: Placement and management of long-term central venous access catheters and ports. AJR, 161: 385–393, 1993.
16.
FonkalsrudE.W., AmentM.E., BerquistW., BurkeM.: Occlusion of the vena cava in infants receiving central venous hyperalimentation. Surg. Gynecol. Obstet., 154: 189–192, 1982.
17.
FonkalsrudE.W., BerquistW., BurkeM., AmentM.E.: Long-term hyperalimentation in children through saphenous central venous catheterization. Am. J. Surg., 143: 209–211, 1982.
GroegerJ., LucasA., BrownA.: Venous access devices in adult cancer patient: catheters vs ports. Presented at the “Twenty-eighth interscience conference on antimicrobial agents and chemotherapy”, p. 158, 1988.
20.
HarveyW.H., PickT.E., ReedK.: A prospective evaluation of the Port-a-Cath implantable venous access system in chronically ill adults and children. Surg. Gynecol. Obstet., 169: 495–500, 1989.
21.
KaufmannJ.A., GreenfieldA.J., FitzpatrickG.F.: Transhepatic cannulation of the inferior vena cava. J. Vase. Intervent. Radiol., 2: 331–334, 1991.
PollackP.F., KaddenM., ByrneW.J.: 100 patient years’ experience with the Broviac silastic catheter for central venous nutrition. JPEN, 5: 32–36, 1981.
27.
ReedW.P., NewmanK.A., WadeJ.C.: Choosing an appropia-te implantable device for long-term venous access. Eur. J. Cancer. Clin., 9: 1383–1391, 1989.
28.
SmithG.Primary postoperative wound infection due to Staphylococcus pyogenes. Curr. Probl. Surg., 16: 30–35, 1979.
29.
ThomasP.R.S., SinnettH.D.: An evaluation of prolonged venous access catheters in patients with leukaemia and other malignancies. Eur. J. Surg. Onc., 14: 63–68, 1988.
30.
WilliardW., CoitD., LucasA., GroegerJ.F.: Long-term vascular access via the inferior vena cava. J. Surg. Onc., 46: 162–166, 1991.
